Efficacy and Safety of Dulaglutide by Baseline HbA1c in Chinese Patients with Type 2 Diabetes: A Post Hoc Analysis

Autor:	Hai Ya Wu, Miao Yu, Xiao Feng Lv, Guo Yue Yuan, Bin Zhang
Rok vydání:	2020
Předmět:	medicine.medical_specialty Insulin glargine endocrine system diseases Endocrinology Diabetes and Metabolism 030209 endocrinology & metabolism Type 2 diabetes 030204 cardiovascular system & hematology Hypoglycemia Lower risk 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Weight loss Internal medicine Type 2 diabetes mellitus Baseline HbA1c Internal Medicine medicine Dulaglutide Original Research business.industry Glimepiride nutritional and metabolic diseases medicine.disease chemistry Glycated hemoglobin medicine.symptom business medicine.drug
Zdroj:	Diabetes Therapy
ISSN:	1869-6961 1869-6953
Popis:	Introduction To evaluate the efficacy and safety of dulaglutide 0.75 and 1.5 mg in patients with type 2 diabetes mellitus (T2DM) by baseline glycated hemoglobin (HbA1c)
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78ec129dbbd6d1fd121dcbfabc4d69a0 https://doi.org/10.1007/s13300-020-00804-2 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.